UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
BMJ, ISSN 0959-8138, 02/2006, Volume 332, Issue 7537, pp. 325 - 327
Medical research | Lung diseases | Medical specialists | Placebos | Hospital admissions | Venous thrombosis | Research | Pulmonary embolisms | Bleeding | Phlebography | Diseases | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | General aspects | Medical sciences | Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous | Blood and lymphatic vessels | Polysaccharides - therapeutic use | Acute Disease | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Polysaccharides - adverse effects | Anticoagulants - therapeutic use | Male | Treatment Outcome | Hospitalization | Anticoagulants - adverse effects | Bed Rest - adverse effects | Disease-Free Survival | Thromboembolism - prevention & control | Female | Venous Thrombosis - prevention & control | Aged | Hemorrhage - chemically induced | Chronic Disease | Clinical trials | Critical care | Older people | Blood clots | Index Medicus | Abridged Index Medicus
Journal Article
Drugs (New York, N.Y.), ISSN 0012-6667, 2002, Volume 62, Issue 11, pp. 1686 - 1687
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2009, Volume 373, Issue 9676, pp. 1673 - 1680
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Thiophenes - therapeutic use | Arthroplasty, Replacement, Knee - adverse effects | Follow-Up Studies | Thiophenes - adverse effects | Humans | Middle Aged | Venous Thrombosis - diagnostic imaging | Male | Enoxaparin - therapeutic use | Incidence | Rivaroxaban | Sensitivity and Specificity | Female | Venous Thrombosis - prevention & control | Morpholines - adverse effects | Morpholines - therapeutic use | Double-Blind Method | Hemorrhage - epidemiology | Risk Reduction Behavior | Administration, Oral | Anticoagulants - therapeutic use | Treatment Outcome | Venous Thrombosis - etiology | Phlebography | Analysis of Variance | Venous Thrombosis - epidemiology | Aged | Hemorrhage - chemically induced | Prevention | Enoxaparin | Anticoagulants (Medicine) | Dosage and administration | Thrombophlebitis | Comparative analysis | Risk factors | Studies | Blood transfusions | Sensitivity analysis | Medical imaging | Hospitals | Protease inhibitors | Surgery | Joint surgery | Drug therapy | Thrombosis | Patients | Veins & arteries | Index Medicus | Abridged Index Medicus | Knee | Venous Thrombosis | Oral | Hemorrhage | epidemiology | Thiophenes | Administration | Anticoagulants | chemically induced | Arthroplasty | Replacement | prevention & control | radiography | Morpholines | Kirurgi | etiology | adverse effects | therapeutic use
Journal Article
The New England journal of medicine, ISSN 0028-4793, 02/2012, Volume 366, Issue 7, pp. 601 - 609
Public health. Hygiene-occupational medicine | Public health. Hygiene | Biological and medical sciences | General aspects | Medical sciences | Prevention and actions | Double-Blind Method | Hemorrhage - epidemiology | Humans | Risk Factors | Kaplan-Meier Estimate | Heparin, Low-Molecular-Weight - adverse effects | Antineoplastic Agents - therapeutic use | Heparin, Low-Molecular-Weight - therapeutic use | Incidence | Neoplasms - drug therapy | Venous Thromboembolism - etiology | Fibrinolytic Agents - adverse effects | Fibrinopeptide A - adverse effects | Neoplasms - complications | Venous Thromboembolism - prevention & control | Fibrinopeptide A - therapeutic use | Antineoplastic Agents - adverse effects | Fibrinolytic Agents - therapeutic use | Adult | Venous Thromboembolism - epidemiology | Drugs | Cancer patients | Care and treatment | Drug utilization | Anticoagulants (Medicine) | Dosage and administration | Product/Service Evaluations | Thromboembolism | Drug therapy | Health aspects | Methods | Thrombolytic therapy | Anticoagulants | Embolisms | Prophylaxis | Clinical trials | Metastasis | Thrombosis | Cancer therapies | Patients | Bleeding | Embolism | Metastases | Studies | Chemotherapy | Heparin | Solid tumors | Health risk assessment | Drug dosages | Cancer | Index Medicus | Abridged Index Medicus | Life Sciences
Journal Article
The New England journal of medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 9, pp. 823 - 833
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Anticoagulants - administration & dosage | Double-Blind Method | Atrial Fibrillation - drug therapy | Humans | Postoperative Complications - prevention & control | Heparin, Low-Molecular-Weight - adverse effects | Warfarin - adverse effects | Male | Anticoagulants - adverse effects | Warfarin - administration & dosage | Perioperative Period | Thromboembolism - prevention & control | Adult | Female | Hemorrhage - chemically induced | Heparin, Low-Molecular-Weight - administration & dosage | Elective Surgical Procedures | Prevention | Care and treatment | Warfarin | Usage | Atrial fibrillation | Clinical trials | Dosage and administration | Hemorrhage | Risk factors | Cardiac arrhythmia | Anticoagulants | Stroke | Transient ischemic attack | Body weight | Preventive medicine | Patients | Bleeding | Embolism | Fibrillation | Ischemia | Surgery | Heparin | Thromboembolism | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 06/2008, Volume 358, Issue 26, pp. 2776 - 2786
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | General aspects | Orthopedic surgery | Prevention and actions | Biological and medical sciences | Medical sciences | Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases | Thiophenes - therapeutic use | Pulmonary Embolism - prevention & control | Venous Thromboembolism - mortality | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Middle Aged | Male | Enoxaparin - therapeutic use | Pulmonary Embolism - epidemiology | Enoxaparin - adverse effects | Rivaroxaban | Venous Thromboembolism - prevention & control | Aged, 80 and over | Adult | Arthroplasty, Replacement, Knee | Female | Venous Thrombosis - prevention & control | Venous Thromboembolism - epidemiology | Morpholines - adverse effects | Morpholines - therapeutic use | Double-Blind Method | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Venous Thrombosis - epidemiology | Aged | Enoxaparin | Arthroplasty | Blood coagulation factors | Comparative analysis | Health aspects | Patient outcomes | Knee | Comparative studies | Clinical trials | Joint surgery | Drug therapy | Clinical outcomes | Blood clots | Index Medicus | Abridged Index Medicus
Journal Article
Thrombosis and haemostasis, ISSN 0340-6245, 11/2012, Volume 108, Issue 5, pp. 876 - 886
Recommendations | rivaroxaban | practical management | anticoagulant | Consensus Paper | Rivaroxaban | Anticoagulant | Practical management | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Hematologic and hematopoietic diseases | Biological and medical sciences | Blood coagulation. Blood cells | Molecular and cellular biology | Medical sciences | Platelet diseases and coagulopathies | Thiophenes - therapeutic use | Anticoagulants - administration & dosage | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Male | Thiophenes - administration & dosage | Dabigatran | Warfarin - administration & dosage | Venous Thromboembolism - prevention & control | Benzimidazoles - administration & dosage | Arthroplasty, Replacement, Knee | Female | Venous Thrombosis - prevention & control | beta-Alanine - analogs & derivatives | Morpholines - adverse effects | Morpholines - therapeutic use | Blood Loss, Surgical - prevention & control | Stroke - prevention & control | Venous Thrombosis - drug therapy | Atrial Fibrillation - drug therapy | Morpholines - administration & dosage | beta-Alanine - administration & dosage | Anticoagulants - therapeutic use | Arthroplasty, Replacement, Hip | Clinical Trials as Topic | Anticoagulants - adverse effects | Pregnancy | Practice Guidelines as Topic | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | recommendations
Journal Article
The American heart journal, ISSN 0002-8703, 2012, Volume 163, Issue 1, pp. 13 - 19.e1
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Heart | Neurology | Cardiac dysrhythmias | Blood. Blood coagulation. Reticuloendothelial system | Pharmacology. Drug treatments | Biological and medical sciences | Vascular diseases and vascular malformations of the nervous system | Medical sciences | Prospective Studies | Anticoagulants - administration & dosage | Global Health | Atrial Fibrillation - drug therapy | Humans | Risk Factors | Atrial Fibrillation - complications | Stroke - complications | Stroke - drug therapy | Patient Selection | Multicenter Studies as Topic | Atrial Fibrillation - mortality | Registries | Stroke - mortality | Longitudinal Studies | Research Design | Cohort Studies | Stroke (Disease) | Anticoagulants (Medicine) | Atrial fibrillation | Risk factors | Anticoagulants | Stroke | Clinical medicine | Veins & arteries | Blood clots | Recruitment | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 05/2002, Volume 359, Issue 9319, pp. 1715 - 1720
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Polysaccharides - therapeutic use | Double-Blind Method | Hospital Mortality | Humans | Middle Aged | Postoperative Complications - prevention & control | Arthroplasty, Replacement, Hip | Male | Enoxaparin - therapeutic use | Preoperative Care | Enoxaparin - administration & dosage | Postoperative Care | Fibrinolytic Agents - therapeutic use | Aged, 80 and over | Adult | Female | Polysaccharides - administration & dosage | Venous Thrombosis - prevention & control | Aged | Fibrinolytic Agents - administration & dosage | Evaluation | Artificial hip joints | Complications | Surgery | Enoxaparin | Venous thrombosis | Anticoagulants (Medicine) | Risk factors | Hip joint | Blood vessels | Medical research | Drug therapy | Anticoagulants | Embolisms | Risk reduction | Risk | Thrombosis | Patients | Bleeding | Hip | Embolism | Catheters | Molecular weight | Molecular chains | Prevention | Low molecular weights | Heparin | Health risk assessment | Thromboembolism | Index Medicus | Abridged Index Medicus
Journal Article